Nutrigenomics Market: Global Industry Size, Share, Growth, Strategies, Analysis and Forecast 2018 to 2026

The latest market report published by Credence Research, Inc. “Global Nutrigenomics Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global nutrigenomics market was valued at US$ xx Mn in 2017, and is expected to reach US$ xx Mn by 2026, expanding at a CAGR of 16.3% from 2018 to 2026.

Browse the full report Nutrigenomics Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/nutrigenomics-market

Market Insights

Nutrigenomics is a branch of medical science where in the chronic disease are studied at genome level and nutritious diet is recommended for its treatment accordingly. There are no regulatory sanctions against any reagents and kits pertaining to nutrigenomics market. However ambiguity still persists regarding the ethical issues related to disclosure of genetic information of consumers through healthcare providers and clinical laboratories.

Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59477

Reagents and kits are reigning the product segment for nutrigenomics market. The key attributes responsible for its dominance are rampant growth in clinical laboratories worldwide and rising prevalence of chronic diseases such as obesity, diabetes, cardiovascular complication and cancer. Services segment is going to register impressive growth on account of technical innovations in IT healthcare services and apps. Mandatory generation of Electronic Health Record (EHR) of patients have given an impetus to the services segment.

As per the latest statistics provided by World Health Organization (WHO) in 2016, approximately 1.9 billion adults were reported overweight. The factors for this rampant growth in obesity are craving for junk food, sedentary lifestyle and leptin resistance. Chronic diseases will be responsible for three-fourths of the global mortality by 2020. Chronic diseases are being studied at genetic level to understand their etiology and how it can be reversed by nutritional science.

Currently saliva and buccal swabs are together dominating the test segment for nutrigenomics market. Consumers show a great inclination towards the oral sample collection method due to its inherent advantageous features such as quick, ease of collection, o pain and venipuncture associated with sample collection. Researchers are diligently working to address the bacterial contamination issue which destabilizes the DNA collected in oral samples. Other DNA collection methods such as hair and urine are being the cynosure of clinical research on account of factors such as less sample volume required, excellent storage and DNA quantification by techniques such as PCR.

North America is leading the regional segment for nutrigenomics market. Rising prevalence of chronic disease and rampant growth in the number of clinical laboratories drive the nutrigenomics market growth in North America. In Europe the government healthcare agencies have invested huge funds in academia research actively engaged in nutrigenomics studies. Increasing public health awareness also have a positive impact on the nutrigenomics market growth in North America. Asia Pacific is a potential market for key players associated with nutrigenomics to establish clinical laboratories and retail outlets. Untapped market in rural areas has a constructive effect on the nutrigenomics market growth in Asia Pacific.

Pharmaceutical companies providing reagents and kits to determine the nutrigenomics of human beings are Cura Integrative Medicine, Centogene, Genomix Nutrition, Inc., Metagenics, Inc., NutraGene, Nutrigenomix, Navigenics, XCODE Life Sciences, Pvt. Ltd., WellGen, Inc. and 23&Me, Inc.

Key Market Movements:

  • Rampant growth of clinical laboratories and increasing number of people suffering with chronic disease worldwide
  • Technical innovation in the IT healthcare services provided and availability of low cost reagent and test kits
  • Paradigm shift in the approach to treat lifestyle disorder analyzing disease etiology at genetic level and recommending nutrition respectively

Here you can get an updated sample on this report: https://www.credenceresearch.com/sample-request/59477

Veterinary Radiography System Market Size, Share, Growth, Trends, Regional Outlook, Competitive Strategies and Forecast 2018 to 2026

The latest market report published by Credence Research, Inc. “Global Veterinary Radiography System Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global veterinary radiography system market was valued at US$ xx Mn in 2017, and is expected to reach US$ xx Mn by 2026, expanding at a CAGR of 6.5% from 2018 to 2026.

Browse the full report Veterinary Radiography System Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/veterinary-radiography-system-market

Market Insights

Veterinary radiography system is an important diagnostic technique used frequently in veterinary practice throughout the globe. Sedation is given while performing diagnosis to stable the animal and reduce its anxiety. Over the last 2 decades there has been a paradigm shift in animal imaging industry from conventional computed radiography to digital radiography. Medical device manufacturers are striving earnestly towards value addition by ensuring high shelf life of records, reduced image generation time and immediate interpretation. Digital images are transferred to remote locations by employing teleradiology. Pioneers such as Canon, Inc. and IDEXX Laboratories are developing digital radiography system that has excellent spatial resolution quality. Portable digital x-ray devices will be the latest trendsetter during the forecast period. Carestream Health is providing digital radiography systems which reduces the number of repeated x-rays taken for the same anatomical position and minimizes the time spent in routine maintenance.

Inquiry Before Buying For Veterinary Radiography System Market Report: https://www.credenceresearch.com/inquiry-before-buying/59428

Analog x-ray are conventional radiography devices which employs CR cassette for image generation. They are known for its low cost and high degree of robustness & reliability in diagnosing large companion animals such as equine and bovine cattle. In the near future the digital x-ray devices are going to completely replace analog x-ray devices. The inherent features associated with digital x-ray devices are short image process time, excellent data archiving platform, flat panel detectors and less labor intensive while operating the device.

Computed radiography systems are preferred by veterinarians owing to its inherent features such as software based evaluation & reporting, less exposure and processing time and reusable imaging plates. Digital radiography will showcase excellent growth during the forecast period on account of excellent shelf life of record and increasing demand for Digital Imaging and Communication in Medicine (DICOM) software.

Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59428

In the present scenario North America is leading the veterinary radiography systems regional segment. Increasing number of animal diseases and infection and increasing awareness of preventive care in animals by American Veterinary Medical Association (AVMA) drive the market growth in North America. In Europe growing humanization and increased consideration of companion animals as family produces an inelastic demand for pet treatment and healthcare. Asia Pacific serves as a lucrative market on account of rising prevalence of zoonotic diseases and developing meat and dairy industry. Untapped market in remote areas of Latin America provides potential platform for key players to promote business expansion activity in the region.

The major players engaged in the manufacturing of radiography systems are Canon, Inc., Carestream Health, Fujifilm Holding Corporation, Heska Corporation, IDEXX Laboratories, iM3/Durr Medical, Philips Healthcare, Siemens Healthcare GmbH, Vetel Diagnostics and VIDISCO.

Key Market Movements:

  • Rising prevalence of zoonotic diseases
  • Increasing adoption of companion animals and rising awareness of animal health
  • Technological revolution from conventional film based x-ray devices to seamless, real time based high quality image producing digital radiography systems

Request For Customization For Veterinary Radiography System Market Report: https://www.credenceresearch.com/request-for-customization/59428

Dental Bone Graft Substitutes And Other Biomaterials Market Size, Share, Growth, Trends, Regional Outlook, Competitive Strategies and Forecast 2018 to 2026

The latest market report published by Credence Research, Inc. “Global Dental Bone Graft Substitutes and Other Biomaterials Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global dental bone graft substitutes and other biomaterials market was valued at US$ 740.3 Mn in 2017, and is expected to reach US$ 1,786.0 Mn by 2026, expanding at a CAGR of 10.3% from 2018 to 2026.

Market Insights

Dental bone grafting is a surgical procedure wherein the missing teeth are replaced by employing grafts obtained from natural, ceramic, composite or polymeric material. Bone grafts finds tremendous application in dental implant surgery as a scaffold and filler to stimulate bone formation and facilitate wound healing. Bone grafts are highly biocompatible and biodegradable preventing occurrence of any antigen-antibody reaction. The factors responsible for the dental bone graft substitutes and other biomaterials market growth are rising prevalence of dental deformities, excellent dental reforms throughout the globe and pioneering technology adopted by major players to provide diverse range of products pertaining to dental surgery.

Browse the full report Dental Bone Graft Substitutes and Other Biomaterials Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/dental-bone-graft-substitutes-and-other-biomaterials-market

Allografts are considered as the most desired dental bone grafts due to its inherent features such as excellent osteoconductive and osetoinductive properties. They are extracted from cadavers donated bones which are sterilized and freeze dried in bone banks. Recurring infection after transplantation hinders the allografts market growth. Xenograft is gaining popularity on account of its availability in huge quantities from bovine and coral sources. It finds application in dental surgery as calcium matrix. Synthetic materials such as ceramic, hydroxyapatite and calcium phosphate are used in combination with growth factors such as TGF-beta, BMP-4, BMP-2 etc., to facilitate jawbone healing by inducing differentiation to osteoblasts.

Inquiry Before Buying For Dental Bone Graft Substitutes And Other Biomaterials Market Report: https://www.credenceresearch.com/inquiry-before-buying/59427

As per the research findings of American Academy of Periodontology (AAP) approximately half of the American adult population suffer from gum disease with periodontitis having a share of 47.2%. The major parameters responsible for the dominance of North America in dental grafts market are the rising prevalence of oral disease and affordable reimbursement scenario related to dental implant procedures. Proactive role adopted by European Medical Agency (EMA) in expediting the dental bone grafts approval and domicile of pioneers such as Geistlich Pharma AG, DENTSPLY International, Inc., and Institut Straumann AG propel the market growth In Europe. Asia Pacific will register excellent growth during the forecast period owing to the increasing number of patients suffering with jawbone atrophy, rising incidence of facial trauma and growing medical tourism.

Archrivals competing in the market are ACE Surgical Supply Company, Inc., Geistlich Pharma AG., Biohorizons IPH, Inc., Sigma Graft Biomaterials, Biomet, Inc., DENTSPLY International, Inc., DePuy Synthes Companies, Institut Straumann AG, Medtronic, Plc., and Zimmer Holdings, Inc.

Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59427

Key Market Movements:

  • Rising prevalence of periodontal disorders such as gingivitis and periodontitis
  • Increasing popularity of dental implant surgery using synthetic materials such as ceramic, hydroxyapatite and bioactive glass either alone or in combination
  • Affordable reimbursement scenario for dental bone graft procedures in developed countries such as U.S. Australia, Germany etc.

Request For Customization For Dental Bone Graft Substitutes And Other Biomaterials Market Report: https://www.credenceresearch.com/request-for-customization/59427

Travel Vaccines Market Size, Share, Growth, Trends, Regional Outlook, Competitive Strategies and Forecast 2018 to 2026

The latest market report published by Credence Research, Inc. “Global Travel Vaccines Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global travel vaccines market was valued at US$ 3,592.1 Mn in 2017, and is expected to reach US$ 6,886.7 Mn by 2026, expanding at a CAGR of 7.5% from 2018 to 2026.

Market Insights

The medical branch engaged in the prevention and management of health problems in international travelers is called as Emporiatrics. Nowadays it has become compulsory for outbound visitors to get vaccination before boarding for travel or at the port of entry of their travel destination. Travel vaccines is usually taken 4 to 6 weeks before travel in order to build immunity against viral and microbial invasion. In comparison to pharmaceutical market the travel vaccines market is very small and concentrated on both the demand and supply chain. It is a very highly regulated market with its growth highly reliable on personal purchase and donations. The limitations associated with travel vaccines market are high cost and stringent regulatory norms sanctioned by regional healthcare authorities.

Browse the full report Travel Vaccines Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/travel-vaccines-market

In the current scenario routine vaccination holds the largest market share by type in the travel vaccines market. The major parameters responsible for the dominance of routine vaccination are the rising prevalence of infectious diseases such as tuberculosis, influenza and MMR (measles, mumps and rubella). On physicians prescription outbound travelers take recommended vaccination to mitigate infections such as Japanese encephalitis, cholera and diarrhea. It is studied that sudden change in temperature, altitude, humidity, and poor hygiene make visitors ill hence, recommended vaccination has gained prominence as a preventive measure. Required vaccination will exhibit excellent growth owing to key factors such as sudden outbreak of fatal diseases such as ebola, zika, yellow fever and Middle East respiratory syndrome.

Inquiry Before Buying For Travel Vaccines Market Report: https://www.credenceresearch.com/inquiry-before-buying/59416

As per the facts provided by U.S. International Air Passenger Statistics Report in 2017, approximately 38.33 million citizens travelled abroad for recreational, business and religious purposes. Center for Disease Control and Prevention (CDC) has stipulated stringent healthcare policies making vaccination compulsory for outbound travelers to mitigate viral and bacterial infection. Favorable reimbursement scenario and domicile of key players have a positive spiraling effect on the travel vaccines market growth in North America. European Medical Agency has sanctioned stringent norms for the effective screening and recommended vaccination of travelers visiting Europe. Asia Pacific will highlight excellent growth throughout the forecast period owing to key factors such as rising prevalence of infectious disease and poor hygiene in developing countries such as India, China, Pakistan and Bangladesh. Middle East healthcare regulatory bodies perform compulsory vaccination of the haj piligrims at the port of entry to prevent the spread the infection of Middle East respiratory syndrome.

Major players providing travel vaccines are Baxter AG, Bharat Biotech, GlaxoSmithkline, Plc., Inovio Pharmaceuticals, Inc., Merck & Co., Inc., Novartis AG, PaxVax Corporation, Sanofi Pasteur SA, Valneva SE and VBI Vaccines, Inc.

Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59416

Key Market Movements:

  • Rising prevalence of infectious diseases and increasing number of travelers throughout the globe
  • Proactive government policies in promoting vaccination in all age group to curb the spread of infectious disease
  • Favorable reimbursement scenario and rise in per capita income to drive the travel vaccines market growth

Request For Customization For Travel Vaccines Market Report: https://www.credenceresearch.com/request-for-customization/59416

Implant Biomaterials Market Size, Share, Growth, Trends, Regional Outlook, Competitive Strategies and Forecast 2018 to 2026

The latest market report published by Credence Research, Inc. “Implant biomaterials Market: Growth, Future Prospects, and Competitive Analysis, 2018 – 2026” the implant biomaterials market was valued at US$ 34.8 Mn in 2017 and expected to reach US$ 64.0 Bn by 2026 at a CAGR of 7.0 % during the forecast period from 2018 to 2026.

Browse the full report Implant Biomaterials Market – Growth, Future Prospects and Competitive Analysis, 2018-2026 report at https://www.credenceresearch.com/report/biomaterials-for-implantable-devices-market

Market Insights

The global implant biomaterials market show productive growth during the forecast period from 2018 to 2026 attributed to an increase in orthopedic, cardiovascular and dental implant procedures globally. Growing prevalence of heart diseases, dental issues (majorly tooth decay), and bone infections, leading to the replacement of hip or knee are major factors driving the global market. External factors driving the demand in the market comprise new technology assessment in the smart digital dental and orthopedic industry, advancement in CAD/CAM systems, 3D printing technology, rising demand for customized implants and increasing medical tourism are enhancing the growth of the market during the forecast period. Increasing implantation procedures with metal and metal alloys, ceramics, and composite materials are in high demand globally.

Inquiry Before Buying For Implant Biomaterials Market Report: https://www.credenceresearch.com/inquiry-before-buying/59423

Manufacturers are also focusing on modifying the material properties of composite materials and bioabsorbables with fillers such as bioactive ceramics. In tissue engineering, modern developments have concentrated on biological essentials to use cells, and signaling elements for further enhancement of an organ structure. The growing field of cosmetic dentistry is enhancing the overall demand for aesthetic restorations. Manufacturers are continuously focusing on improving the coatings to supplement the function of existing medical device implants, with an approach to improve and standardize their incorporating antimicrobial properties and osseointegrative qualities.

Significant growth in the target patient pool in the developing nations such as India, Brazil, Argentina, China, Mexico, Indonesia, and others, increasing acceptance of advanced and branded biomaterials along with increasing number of dental hospitals, orthopedic clinics, and ambulatory surgical centers are contributing to the overall development of the market.

Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59423

The increased cost of the orthopedic, dental, cardiovascular implant procedures, lack of awareness, issues related to post-surgery infection, implant failure, high preference for metal implants in the developing nations, and the inconsistent reimbursement policies are few external factors restraining the overall growth of the implant biomaterials market globally. External factors driving the market growth include increasing awareness related to advanced biomaterials and their respective applications, rising minimally invasive surgeries, new product launches, and mergers and acquisitions are fueling the demand for implant biomaterials in near future.

Key Market Movements:

  • Globally, the implant biomaterials market remains to exhibit a profitable growth with a CAGR of 7.0% for the period from 2018 to 2026
  • Based on the material type, the metal alloys segment shows lucrative growth with increasing applications in the orthopedic and dental restorative procedures. Higher technology assessment in the products with computer-aided technology is gaining traction in the market.
  • Asia Pacific, Eastern Europe, and Latin America show promising opportunities and shows growing CAGR during the forecast period owing to rising awareness advanced implant biomaterials along with increasing implant procedures
  • Increasing number of advanced hospital and dental healthcare settings, easy accessibility of branded products with enhanced digital applications to patients, and rising healthcare spending in Brazil, India, China, Mexico, Russia, and Japan will drive the growth of the market during the forecast period
  • Major players in this vertical are Evonik Industries AG, Celanese Corp., Royal DSM and Invibio, Inc., DuPont, AdvanSource Biomaterials Corp., Collagen Matrix, Inc., Invibio Ltd., Collagen Solutions Plc., Keystone Dental, Inc., Surgival, SBM France, Zimmer Biomet and others

Request For Customization For Implant Biomaterials Market Report: https://www.credenceresearch.com/request-for-customization/59423

Chromatography Systems Market Size, Share, Growth, Trends, Regional Outlook, Competitive Strategies and Forecast 2018 to 2026

The latest market report published by Credence Research, Inc. “Chromatography Systems Market Growth, Future Prospects, and Competitive Analysis, 2018 – 2026” the global chromatography systems market was valued at US$ 6.2 Bn in 2017 and expected to reach US$ 11.4 Bn by 2026 at a CAGR of 7.0% during the forecast period from 2018 to 2026.

Market Insights

The global chromatography systems market shows productive growth during the forecast period from 2018 to 2026, attributed to increase in need for separation techniques in pharmaceutical industry, biotechnology, agriculture, food and environmental analysis. More than, 60% of analysis on a global scale is presently done by chromatography techniques.

Browse the full report Chromatography Systems Market – Growth, Future Prospects and Competitive Analysis, 2018-2026 report at https://www.credenceresearch.com/report/chromatography-systems-market

The advanced separation techniques has a numerous advantages over traditional techniques such as crystallization, solvent extraction, and distillation. Novel technology progression in portable or mobile and transportable chromatography systems, the rise in manufacturing and demand for downstream processing are driving the market growth. Production of top quality systems with increased cost such as ultra-high-pressure liquid chromatography (UHPLC) and other standalone-automated systems are other prominent market drivers. The gas chromatography system is leading the global market owing to its high proficiency output along with enhanced applications, mainly biotech and pharmaceuticals, ease of use, and availability of advanced automated systems.

Inquiry Before Buying For Chromatography Systems Market Report: https://www.credenceresearch.com/inquiry-before-buying/59425

Development of column chromatography systems and its clinical benefits is gaining traction in the market. Moreover, growing applications of standalone systems in nutraceutical companies, cosmetic industries and environmental agencies will further generate revenue share during the forecast period. Other major factors driving the growth include rapid utilization of advanced systems along with chromatography data systems with enhanced productivity. Major external factors include expansion of biotech and other diagnostic facilities with high quality systems, new product launches, acquisitions and partnerships with small-scale manufacturers is generating maximum revenue share in the global market. In addition, strategic agreements by private players is growing dramatically, majorly in countries such as India, China, Singapore, Japan, and Vietnam.

Increasing advancements in R&D for automated and portable chromatography systems technology, government and organizational support for various chromatography applications such as genetic engineering, diagnostics, drug discovery and water/fluid separation analysis, etc. are further going to spur revenue growth during the forecast period.

Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59425

However, the high cost of the chromatography systems, strict regulations related to the clinical use of automated standalone chromatography systems, less awareness about the new separation techniques, and lack of skilled experts in the developing nations to operate chromatography, are few factors limiting the growth of the chromatography systems market globally. Other external factors include scarce availability of advanced automated systems, and economic slowdown are few restraints limiting the overall market growth.

Key Market Movements:

  • Globally, the chromatography systems market remains to exhibit a profitable growth with a CAGR of 7.0% for the period from 2018 to 2026
  • Higher technology assessment in the liquid chromatography systems segment is gaining traction in the market
  • Asia Pacific, Latin America, and Eastern Europe to show promising opportunities during the forecast period owing to increasing awareness along with adoption of advanced automated systems
  • Development of enhanced applications in the portable systems, accessibility of branded systems in developed nations, and increasing usage in food, biotech and environmental analysis will contribute to the growth of the market
  • Major players in this vertical are Thermo Fisher Scientific, Waters Corporation, Shimadzu Corporation, OI Analytical (Xylem), Quadrex, PerkinElmer, Affymetrix, Inc., GE Healthcare, Roche Diagnostics Limited, Schutz Gmbh, Bio-Rad Laboratories, Pall Corporation and others

Request For Customization For Chromatography Systems Market Report: https://www.credenceresearch.com/request-for-customization/59425

Aortic Stent Grafts Market Size, Share, Growth, Trends, Regional Outlook, Competitive Strategies and Forecast 2018 to 2026

According to the latest report published by Credence Research, Inc. “Aortic Stent Grafts Market– Growth, Future Prospects and Competitive Analysis, 2018-2026,” the Aortic Stent Grafts market was valued at USD 1,605.3 Mn in 2017, and is expected to reach USD  3,293.4 Mn by 2026, expanding at a CAGR of 8.1% from 2018 to 2026.

Market Insights

Endovascular aneurysm repair (EVAR) is a novel treatment against abdominal or thoracic aortic aneurysm with a major advantage of being minimally invasive and highly efficient compared to open surgery. According to Centers for Diseases Control and Prevention, aortic aneurysm arises in 3% of people above the age 50, and about 5% to 8% of men above the age 65. The people at highest risk are men who smoke and possess hypertension. In case left undiagnosed, an aortic aneurysm with a diameter exceeding 6 cm has a 5-year mortality rate of 25% to 40% which is alarming. The diagnostics techniques have developed significantly over the decade leading to early disease diagnosis. Introduction of various medical platforms open for patients and doctors have increased the awareness and knowledge of patients about the risks related to lifestyle diseases and preventive measures.

Browse the full report Aortic Stent Grafts Market – Growth, Future Prospects and Competitive Analysis, 2018-2026 report at https://www.credenceresearch.com/report/aortic-stent-grafts-market

Aortic stent grafts market segmented on the basis of products such as abdominal aortic stent grafts and thoracic aortic stent grafts. Abdominal aortic stent grafts accounted for the largest market share in year 2017, due to key factors driving the market are high prevalence of abdominal aortic aneurysm, rising preference for minimally invasive surgeries, and technological development in aortic stent grafts manufacturing.

Market segmentation carried out on the basis of end-user comprises hospitals and ambulatory care centers. Hospitals segment was identified as the largest and fastest growing segment throughout the forecast period from 2018 to 2026 due to increasing number of hospitals in Asia Pacific to meet the needs of growing population, and hospitals are identified as the first point of contact for patients suffering with aneurysm. However, the United States is the only country where scenario is different due to increasing preference for ambulatory care centers over hospitals due to cost efficiency, and high accessibility.

Inquiry Before Buying For Aortic Stent Grafts Market Report: https://www.credenceresearch.com/inquiry-before-buying/59419

Market Competition Assessment:

The aortic stents grafts market is progressing and most of the largest players in the market are focusing on product improvement and minimizing post-surgery complications. The major players functioning in this market are Medtronic Plc, Cardinal Health, Inc., Cook Medical Inc., W.L. Gore & Associates Inc., Terumo Corporation Inc., ENDOLOGIX, INC., Lombard Medical, Inc., CryoLife, Inc., MicroPort Scientific Corporation, Altura Medical, and Aptus Endosystems among others.

Key Market Movements:

  • Increasing prevalence of aneurysm in developed as well as developing countries
  • Prevalence of thoracic aortic aneurysm is around 4.2% of the population living without hypertension. Major cases of thoracic aortic aneurysms occur in the aortic arch or the ascending aorta. In chronic cases aneurysm rupture accounts for 60% of deaths globally.
  • Rising patient awareness related to early disease diagnosis, reimbursement policies, and efficient treatment options
  • High rate of product recalls, scarcity of trained healthcare providers, low awareness regarding new EVAR treatment options among patients and risk of endoleaks are the major restraining factors affecting growth of this market

Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59419

By Product Type Segment 

  • Abdominal Aortic Stent Graft
  • Thoracic Aortic Stent Graft

By End-User Segment

  • Hospitals
  • Ambulatory Surgical Centers

By Geography Segment

  • North America
  • Europe
  • Asia Pacific (APAC)
  • Latin America (LATAM)
  • Middle East & Africa (MEA)

Request For Customization For Aortic Stent Grafts Market Report: https://www.credenceresearch.com/request-for-customization/59419

Electrophoresis Equipment And Supplies Market Analysis, Market Size, Application, Regional Outlook, Competitive Strategies, and Industry Forecasts, 2018 To 2026

The latest market report published by Credence Research, Inc. “Electrophoresis Equipment and Supplies Market Growth, Future Prospects, and Competitive Analysis, 2018–2026” the electrophoresis equipment and supplies market was valued at US$ 1,729.2 Mn in 2017 and projected to reach US$ 2,554.4 Mn by 2026 at a CAGR of 4.4% over the forecast period from 2018 to 2026.

Market Insights

The electrophoresis equipment and supplies market is likely to exhibit a noticeable CAGR during the forecast period from 2018 to 2026. Electrophoresis is a technique mostly used in the lab to separate charged particles or molecules such as deoxyribonucleic acid (DNA), based on the size. Electrophoresis detects and quantifies minute traces of a broad-range of biomolecules in a mixture including nucleic acids, proteins, carbohydrates, and amino acids.

Browse the full report Electrophoresis Equipment and Supplies Market Growth, Future Prospects, and Competitive Analysis, 2018–2026 at https://www.credenceresearch.com/report/electrophoresis-equipment-and-supplies-market

The technique separates DNA fragments and other macromolecules especially proteins & nucleic acids such as ribonucleic acid (RNA), and widely used by life science laboratories for protein analysis & separation. Variables of the market are globally rising prevalence of cancer, genetic disorders, and infectious diseases, increasing research activities coupled with funding in the proteomics and genomics fields, surging number of industry-academic research institutes partnerships, and growing focus on next-generation sequencing (NGS) research activities. A paradigm shift from genomics to proteomics is more beneficial as the proteins are the functional molecules in cells and represent actual conditions, thereby finding rising applications in cancer research. Novel technologies enable the comprehensive analysis of genomes, proteomes, and transcriptomes in health & disease are assisting the cancer research activities.

[Download Free PDF Sample Request]

Major players in this space are Bio-Rad Laboratories, Inc.; Thermo Fisher Scientific Inc.; GE Healthcare; Agilent Technologies, Inc.; Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation); PerkinElmer Inc.; Shimadzu Corporation; Merck KGaA; QIAGEN; and Helena Laboratories. Improved technology, advanced solutions, wide-ranging product portfolio, and well-organized post-sales services are the factors supporting the dominance of these market players. A gradual rise in the number of new market entrants are making the environment highly competitive and the competitive rivalry at a higher level. Two-dimensional gel electrophoresis (2DE) is widely used in biomarker discovery for proteome fractionation and separation in biological samples, thus nurturing the market growth.

Key Market Movements:

  • Globally, the electrophoresis equipment and supplies market will witness a considerable growth at a CAGR of 4.4% over the forecast period from 2018 to 2026
  • Capillary electrophoresis technique is on the rise due to the growth in hyphenated technology, which in turn increasing the adoption of capillary electrophoresis–mass spectrometry (CE-MS). Researchers often use this technique owing to its higher efficiency & resolution, minimum sample & solvent requirements, and on-line detection principle.
  • The research & diagnostics segment held the lion’s share of the market in 2017 due to growing applications of electrophoresis in drug discovery, mounting technological advancements such as automated electrophoresis systems and microchip-based CE diagnostics
  • North America would lead the market throughout the forecast period. This is owing to the presence of key market participants & developed healthcare infrastructure, increasing focus of stakeholders on research projects involving proteins, genes, and biomolecules (nucleic acids, carbohydrates, and amino acids), and rising research activities pertaining to genomics and proteomics in the U.S. and Canada.
  • Asia Pacific is likely to witness comparatively higher market growth rate from 2018 to 2026 due to the presence of robust healthcare research infrastructure & raw materials and reagents manufacturers. Additionally, patent expiries of several drugs are triggering pharmaceutical manufacturers to discover & develop novel or innovative drugs are expected to support the market growth.

Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59413

Neuroprosthetics Market Size, Application, Regional Outlook, Competitive Strategies, and Industry Forecasts, 2018 To 2026

The latest market report published by Credence Research, Inc. “Neuroprosthetics Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global neuroprosthetics market was valued at US$ 5.55 Bn in 2017 and expected to reach US$ 15.81 Bn by 2026, expanding at a CAGR of 12.3% from 2018 to 2026.

Market Insights

Neuroprosthetics involve merger of engineering, biotechnology and neurology applications for treatment and management of several neurological conditions, facilitating restoration of lost movements. Technological advancements have led to development of personalized neuroprosthetics and rehabilitation for neural impairments. Spinal, cochlear and retinal implants are the most prominent examples of technological progress in this field. Additionally, increasing prevalence of neurological disorders occurring both from age or trauma is another key factor supporting the growth of this market.

Browse the full report Neuroprosthetics Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at  https://www.credenceresearch.com/report/neuroprosthetics-market

Conversely, such devices are costly and therefore can be afforded only by patients with high disposable incomes. Implantation of these devices also require significant amount of skill. This has led to greater adoption of neuroprosthetics concentrated in developed markets. Whereas middle- and low-income countries still struggle with the adoption of neuroprosthetics. Awareness also plays a critical role in determining the demand for these therapeutic solutions. Therefore, in emerging markets, improvement in knowledge of neuroprosthetics and government initiatives for improving healthcare conditions are imperative to open market penetration opportunities.

[Download Free PDF Sample Request]

Considering the competitive landscape, several companies have introduced their products encompassing different applications such as traumatic neural conditions, motor neuron disorders and physiological disorders. Though motor neuron disorders accumulate larger revenue share in the global market, the highest number of product approvals are observed for application for physiological disorders. Major physiological conditions for which neuroprosthetics are commercially available include cardiovascular diseases, chronic pain, ophthalmic and auditory disorders.

The growth of neuroprosthetics market in developed regions is mainly attributed to increasing burden of chronic neurological diseases. Therefore as the overall life expectancy and the prevalence of neurological conditions continue to increase, the neuroprosthetics market will be set to attain stability. In the developed regions, U.S., Canada, France, Germany, U.K., the Netherlands and Italy are estimated to be the largest markets, with the U.S. taking the lead.

Globally, disorders and injuries to the brain and spinal cord possess a considerable financial and social burden. In Europe alone, brain disorders are responsible for 35% of the overall disease burden. Persistently growing aging population, and the corresponding growth in financial costs for conventional treatment and management of such conditions has been a key factor for the advent of neuroprosthetics. Spinal cord stimulation is the most widely employed modality in neuroprosthetics. Analgesic property of spinal cord stimulation has established it as the most sought treatment for chronic pain. The modality also finds effective application in the treatment of limb movements. On the other hand, sacral nerve stimulation is estimated to be the fastest progressing segment due to its established efficacy in treating chronic pelvic pain and neurogenic bladder.

Key Market Movements:

  • Perpetually growing prevalence of neurodegenerative diseases such as Alzheimer’s and Parkinson’s
  • Significantly high cost incurred in conventional treatment of traumatic brain injury and spinal cord injuries
  • Increasing disposable incomes and improving awareness in emerging economies of Asia Pacific and Latin America
  • Scarce availability of viable and efficacious treatments for Parkinson’s disease through the conventional mode
  • Growing preference for neuromodulation techniques such as deep brain stimulation and spinal cord stimulation for treating cognitive disorders and debilitating injuries
  • Vigorous collaborative and marketing strategies by international market players
  • Intensive research and development advancing in the field of deep brain stimulation and sacral nerve stimulation

Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59409

 

Cosmetic Implants Market Size, Application, Regional Outlook, Competitive Strategies, and Industry Forecasts, 2018 To 2026

The latest market report published by Credence Research, Inc. “Global Cosmetic Implants Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global cosmetic implants market was valued at US$ 7,971.2 Mn in 2017, and is expected to reach US$ 15,670.5 Mn by 2026, expanding at a CAGR of 7.8% from 2018 to 2026.

Browse the full report Cosmetic Implants Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/cosmetic-implants-market

Market Insights

Cosmetic implants are medical devices which are implanted in the human body through minimal invasive surgical procedures either to improve aesthetic appearance or replace a damaged body part. Technological advancement in the raw materials employed for reconstructive surgical procedures such as breast implant, dental implant and facial implants are driving the cosmetic implants market growth worldwide. 3D printing has been employed by surgeons to perform facial implants resulting in excellent facial aesthetics. The limitation associated with cosmetic implants market growth are high treatment cost, risk of implant malfunction and low reimbursement policies.

[Download Free PDF Sample Request]

Polymers are the largest segment by raw material in the cosmetic implants market. The key factors responsible for the dominance of polymers are its high durability and ability to be folded in different size and shapes favoring minimally invasive reconstructive surgeries worldwide. Biological materials are being widely used due to its excellent biocompatible and non-biodegradable properties.

Dental implants are currently dominating the cosmetic implants application segment on account of key factors such as rising prevalence of dental deformities throughout the globe. Ceramic implants are preferred over metal implants due to excellent aesthetic look. Breast augmentation and breast lifts are gaining immense popularity in the Caucasian and Mongoloid population due to the craving for enhanced physical appearance. Buttock and calf implants have garnered attention over the last decade on account of changing lifestyle and latest fashion trend adopted by women throughout the globe.

According to American Society of Plastic Surgeons (ASPS) in 2016, 17.5 million cosmetic surgeries were performed in the United States. North America currently holds the largest market share in the global cosmetic implants market on account of the increasing demand for surgical procedures such as breast augmentation and facial surgeries. Domicile of key players also augment the positive market growth of cosmetic implants in North America. In Europe the rise in dental deformities has resulted in tremendous demand for maxillofacial surgeries causing a positive traction for dental implants market. Asia Pacific will be highlighting steady growth during the forecast period owing to the rising number of traumatic accidents requiring cosmetic surgery. Rise in per capita income has caused a positive spiraling effect on the cosmetic implants market growth in Asia Pacific region.

Manufacturers providing cosmetic implants are AART, Inc., DENTSPLY International, Inc., Allergan, Inc., GC Aesthetics, Institut Straumann AG, Implantech Associates, Inc., 3M Healthcare, Zimmer Holdings, Inc., Sientra, Inc. and Nobel Biocare Holding AG.

Key Market Movements:

  • Increasing demand for minimally invasive cosmetic implants surgery
  • Technological advancement in the raw materials such as polymers and biological materials used as implants
  • Supportive regulatory environment resulting in positive traction for the cosmetic implants market growth

Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59406